Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Apr
3
2023
 White House OSTP Outlines Goals for U.S. Biotechnology and Manufacturing Bergeson & Campbell, P.C.
Apr
3
2023
 Editors’ Roundtable: Predictions About the Upcoming Farm Bill Bradley Arant Boult Cummings LLP
Apr
3
2023
 FDA Publishes Framework for Digital Health Technologies in Clinical Trials Foley & Lardner LLP
Apr
3
2023
 EPA Proposes National Primary Drinking Water Regulation to Set Stringent Limits on PFAS in Drinking Water, Including Four Newly Targeted Substances Hunton Andrews Kurth
Apr
3
2023
 New Lawsuit Comes Amidst Push to Exclude Juice From “Healthy” Definition Keller and Heckman LLP
Mar
31
2023
 McDermott+Consulting Check-Up: March 31, 2023 McDermott Will & Emery
Mar
31
2023
 New Cosmetics Regulatory Scheme to Reshape Industry's Relationship with FDA McDermott Will & Emery
Mar
30
2023
 Medical Device Developers Now Required to Incorporate Cybersecurity Plans into FDA Premarket Submissions for “Cyber” Devices Mintz
Mar
30
2023
 Food and Chemicals Unpacked: Laying Claim: FTC’s Green Guides Keller and Heckman LLP
Mar
30
2023
 Use of Salt Substitutes Expanded to Help Lower Sodium Intake Keller and Heckman LLP
Mar
30
2023
 The South Korean Food Authority Releases New Rules and Policies Supporting the Development of the Alternative Protein Industry Keller and Heckman LLP
Mar
30
2023
 The Short-Term Consequences of Alabama’s Cannabis Social Equity Policy Bradley Arant Boult Cummings LLP
Mar
29
2023
 FDA Publishes Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market Keller and Heckman LLP
Mar
29
2023
 FDA Issues First Untitled Letter of the Year to HCT/P Manufacturer Sheppard, Mullin, Richter & Hampton LLP
Mar
29
2023
 The BioPharma Patent Cliff: 2023 and Beyond Foley & Lardner LLP
Mar
28
2023
 FDA Revamps Guidance Concerning Use of Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
Mar
28
2023
 De-scheduling vs. Re-scheduling Marijuana: A Dramatic Difference Bradley Arant Boult Cummings LLP
Mar
28
2023
 FSIS Proposes New Rules Regarding U.S. Origin Claims Keller and Heckman LLP
Mar
28
2023
 Weeding Out Employees: The Ups and Downs of Drug-Testing Manufacturing Workforce Jackson Lewis P.C.
Mar
28
2023
 Technical Effect Embodied In Technical Teaching K&L Gates LLP
Mar
27
2023
 FDA Issues Draft Guidance on Dietary Guidance Statements on Food Labels Keller and Heckman LLP
Mar
27
2023
 Last Dance with Mary Jane? Faltering Cannabis Businesses May Have a Bankruptcy Option in Addition to State Law Remedies Bradley Arant Boult Cummings LLP
Mar
25
2023
 EC Committee Issues Final Opinion on Hydroxyapatite (Nano) in Oral Cosmetic Products Bergeson & Campbell, P.C.
Mar
24
2023
 Judge Approves $25M Settlement of Antitrust Action Against J&J for Allegedly Blocking Biosimilars MoginRubin
Mar
24
2023
 Pfizer Expands Cancer Drug Portfolio with $43 Billion Biotech Acquisition MoginRubin
Mar
23
2023
 APHIS Accepting Public Comments on Draft Guide for Submitting Permit Applications for Microorganisms Developed using Genetic Engineering Bergeson & Campbell, P.C.
Mar
23
2023
 California Assembly Members Introduce Bill to Ban Certain Color Additives Keller and Heckman LLP
Mar
23
2023
 FDA Revises Recommendations Regarding Electronic Systems, Records, and Signatures in Clinical Investigations Nelson Mullins
Displaying 2353 - 2380 of 12182
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters